Valuation: Aspen Pharmacare Holdings Limited

Market Cap 62.41B 3.84B 3.31B 3.12B 2.83B 5.33B 368B 5.41B 36.58B 14.34B 184B 14.41B 14.1B 613B P/E 2026 *
14.3x
P/E 2027 * 12.1x
Enterprise Value 75.28B 4.63B 4B 3.76B 3.42B 6.43B 444B 6.53B 44.13B 17.3B 222B 17.38B 17B 739B EV / Sales 2026 *
2x
EV / Sales 2027 * 1.56x
Free-Float
59.64%
Yield 2026 *
1.89%
Yield 2027 * 1.79%

Last Transcript: Aspen Pharmacare Holdings Limited

1 day-0.98%
1 week-4.27%
Current month-5.73%
1 month-6.50%
3 months+0.81%
6 months+12.44%
Current year+20.34%
1 week 138.69
Extreme 138.69
147.06
1 month 138.69
Extreme 138.69
158.55
Current year 104.38
Extreme 104.38
160.79
1 year 90.7
Extreme 90.7
160.79
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
281.67
10 years 64.07
Extreme 64.07
367.99
Manager TitleAgeSince
Chief Executive Officer 62 1996-12-31
Director of Finance/CFO 61 2008-12-31
Chief Operating Officer 63 1998-12-31
Director TitleAgeSince
Director/Board Member 62 1998-12-31
Director/Board Member 65 1998-12-31
Chairman 58 2015-12-06
Date Insider Type Main position Quantity % Market Cap.
9/27/23 Free

Chief Operating Officer

12,236 0.0027%
9/27/23 Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-4.27%+22.99%-25.53% 3.84B
+1.03%-2.57%+16.45%+66.53% 46.96B
+0.12%-1.59%+47.86%+123.16% 39.63B
-0.92%-3.08%-8.46%+14.92% 12.07B
-0.67%-8.17%+11.84%+69.44% 11.61B
+0.58%0.00%+30.65%+147.62% 9.11B
+0.54%-0.23%+21.04%+40.85% 7.47B
+0.80%+1.82%+43.27%-11.49% 7.18B
-3.28%-2.63%+14.59%+187.68% 6.79B
-0.97%-2.30%-30.37%+24.93% 5.75B
Average -0.39%-1.95%+16.99%+63.81% 15.04B
Weighted average by Cap. +0.10%-2.91%+23.03%+78.97%

Financials

2026 *2027 *
Net sales 37.62B 2.31B 2B 1.88B 1.71B 3.21B 222B 3.26B 22.05B 8.64B 111B 8.69B 8.5B 369B 38.86B 2.39B 2.06B 1.94B 1.76B 3.32B 229B 3.37B 22.78B 8.93B 115B 8.97B 8.78B 381B
Net income 4.8B 295M 255M 240M 218M 410M 28.27B 416M 2.81B 1.1B 14.14B 1.11B 1.08B 47.1B 5B 307M 265M 250M 227M 427M 29.43B 433M 2.93B 1.15B 14.72B 1.15B 1.13B 49.03B
Net Debt 12.88B 792M 684M 644M 585M 1.1B 75.88B 1.12B 7.55B 2.96B 37.95B 2.97B 2.91B 126B -1.74B -107M -92.16M -86.71M -78.81M -148M -10.22B -150M -1.02B -399M -5.11B -401M -392M -17.03B
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
26-08-18 ZAR 140.55 -0.98% 3,249,353
26-08-17 ZAR 141.94 -1.21% 969,449
26-08-14 ZAR 143.68 +0.24% 1,674,274
26-08-13 ZAR 143.33 -1.39% 2,304,506
26-08-12 ZAR 145.35 -1.00% 2,344,824
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
140.55ZAR
Average target price
162.75ZAR
Spread / Average Target
+15.80%

Annual profits - Rate of surprise